News

MAPLE-HCM met its primary endpoint, demonstrating a statistically significant improvement in peak oxygen uptake (pVO 2) from ...
Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long ...
Ascendis Pharma A/S (Nasdaq: ASND) today announced new data from Week 214 of its Phase 2 PaTH Forward Trial showing that long-term treatment with ...
BRUSSELS (Reuters) -EU antitrust regulators, who are examining European satellite company SES's $3.1-billion bid for Intelsat ...
India has approved three Russian insurers, including a unit of top lender Sberbank, to provide marine cover to ships arriving ...